The trials process is the moat. There's already founders using AI to treat their cancers, and it's all about skipping trials and jumping straight to "I consent, I'll fund it, let's try it". The general public might get access to this in 10 years, but employees at AI companies will have access much much sooner.
https://sytse.com/cancer/